Terapia ormonale sostitutiva e malattie cardiovascolari: Popolazioni differenti, rischi differenti

Translated title of the contribution: Hormone replacement therapy and cardiovascular disease: Different populations, different areas

Salvatore Panico, Rocco Galasso, Egidio Celentano, Camilla Ambrosca, Antonio Asti, Luisa Frova, Riccardo Capocaccia, Franco Berrino

Research output: Contribution to journalArticle

Abstract

Observational studies indicate that oral hormone replacement therapy (HRT) in menopause is associated with a 20-40% reduction of coronary risk. Population risk/benefit analyses on mortality after large-scale HRT use indicate that excess deaths can be counted when coronary heart disease is relatively less frequent than breast cancer before age 60 (as occurs in Italy). The decline in mortality trends for coronary heart disease support a word for caution for a large scale use of HRT in the next years even in those populations for which a relative advantage is presently estimated.

Translated title of the contributionHormone replacement therapy and cardiovascular disease: Different populations, different areas
Original languageItalian
Pages (from-to)203-206
Number of pages4
JournalAnnali dell'Istituto Superiore di Sanita
Volume33
Issue number2
Publication statusPublished - 1997

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health

Fingerprint Dive into the research topics of 'Hormone replacement therapy and cardiovascular disease: Different populations, different areas'. Together they form a unique fingerprint.

  • Cite this

    Panico, S., Galasso, R., Celentano, E., Ambrosca, C., Asti, A., Frova, L., Capocaccia, R., & Berrino, F. (1997). Terapia ormonale sostitutiva e malattie cardiovascolari: Popolazioni differenti, rischi differenti. Annali dell'Istituto Superiore di Sanita, 33(2), 203-206.